Division of Clinical Pharmacology, University of Miami

Miami, Florida 33136

0 studies enrolling now · 7 studies all time

What they study most

Focal Segmental Glomerulosclerosis (FSGS), Hepatic Impairment, Liver Disease, Pain, Pharmacokinetics, Renal Function, Renal Impairment

Studies at this site

• Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls — Completed
• Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls — Completed
• Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment — Completed
• Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment — Completed
• Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Mild or Moderate Hepatic Impairment — Completed
• Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients — Completed
• Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects — Completed